{
    "Case ID": "086023",
    "Different Crime": [
        {
            "Crime Name": "unknown",
            "Crime Type": "others",
            "patent_validity": [
                "invalid due to lack of utility"
            ],
            "utility": [
                "failed to demonstrate or soundly predict improvement"
            ],
            "novelty": [
                "achieved high optical purity of 99.8%ee, inventive and not obvious"
            ],
            "obviousness": [
                "non-obvious"
            ],
            "expert_testimony": [
                "analyzed through expert testimonies"
            ],
            "relevant_rule": [
                "valid if demonstrates or soundly predicts utility, novel, and non-obvious"
            ],
            "cause_of_action": [
                "AstraZeneca's patent challenged by Apotex"
            ],
            "procedure_followed": [
                "Federal Court analyzed claims, utility, novelty, and obviousness"
            ],
            "result_of_case": [
                "patent declared invalid, infringement claim dismissed, counterclaim granted"
            ]
        }
    ]
}